1. Elvidge J , Summerfield A , Knies S , et al . Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19. Zenodo 2021. Available: https://zenodo.org/record/5530468
2. Facey KM , Rannanheimo P , Batchelor L , et al . Real-World evidence to support payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders. Int J Technol Assess Health Care 2020:1–10. doi:10.1017/S026646232000063X
3. The “ top 10 ” challenges for health technology assessment: INAHTA viewpoint;O’Rourke;Int J Technol Assess Health Care,2020
4. Vogler S , Haasis MA , Dedet G , et al . Medicines reimbursement policies in europe [internet]. WHO regional office for europe. 2018. Available: https://jasmin.goeg.at/421/
5. Hta programme response to the challenges of dealing with orphan medicinal products: process evaluation in selected European countries;Nicod;Health Policy,2019